4Kalantar SJ,Marks RL, Lambert JR, et al. Dyspepsia due to eosinophilic gastroenteritis [ J ]. Dig Dis Sci, 1997, 42 ( 11 ) :2327-2332.
5Talley N J, Shorter RG, Philips SF,et al . Eosinophilic gastroenteritis : a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues [ J ]. Gut , 1990, 31 ( 1 ) :54-58.
6COOLS J, STOVER EH, BOULTON CL, et al. PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease[J]. Cancer Cell, 2003,3:459-469.
7GOTLIB J, COOLS J, MALONE J M 3rd, et al. The FIP1LI-PDGFRalpha fusion tyrosine kinase in hypereosinophilie syndrome and chronic eosinophillc leukemia: implications for diagnosis, classification, and management[J]. Blood, 2004,103:2879- 2891.
8KLION A D, LAW M A, NOEL P, et al. Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome [J].Blood, 2004, 103 : 2939 - 2941.
9SEFCICK A, SOWTER D, DASGUPTA E, et al. Alemtuzumab therapy for refractory idiopathic hyperosinophilic syndrome[J]. Br J Haematol, 2004,124:558-559.
10PITINI V, TETI D, ARRIGO C, et al. Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report[J]. Br J Haematology, 2004,127 : 477 - 477.
